A COMPARISON OF THE EFFICACY AND SAFETY OF COMBINED HIGHLY PURIFIED HUMAN MENOPAUSAL GONADOTROPIN (HP-HMG) AND HIGHLY PURIFIED URINARY FOLLICLE STIMULATING HORMONE (HP-UFSH) VERSUS HP-HMG ALONE FOR OVARIAN STIMULATION.

被引：1
|
作者：
Miller, C. E. [1 ]
Shapiro, D. [1 ]
Witz, C. A. [2 ]
Willey, R. [3 ]
Heiser, P. W. [3 ]
Ruman, J. [3 ]
Yankov, V. I. [3 ]
机构：
[1] Charles Miller & Associates, Naperville, IL USA
[2] Houston Fertil Inst, Houston, TX USA
[3] Ferring Pharmaceut Inc, Parsippany, NJ USA
来源：
FERTILITY AND STERILITY | 2015年 / 104卷 / 03期
关键词：
D O I：
10.1016/j.fertnstert.2015.07.1008
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-631
引用
收藏
页码：E322 / E323
页数：2
相关论文
共 50 条
  • [21] Highly purified subcutaneous human menopausal gonadotropin (hMG-HP;: Menopur™) does not compromise assisted reproductive technology outcome.
    Allahbadia, GN
    Gandhi, GN
    Merchant, RM
    Kadam, KS
    Karani, JA
    FERTILITY AND STERILITY, 2003, 79 : S21 - S21
  • [22] Title clinical study of letrozole combined low-dose highly purified HMG (Hp-HMG) in patients with clomiphene citrate-resistant polycystic ovary syndrome-related infertility
    Ruan, Xiangyan
    Zhao, Yue
    Mueck, Alfred
    GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 : 63 - 63
  • [23] Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis
    Revelli, Alberto
    Poso, Francesca
    Gennarelli, Gianluca
    Moffa, Federica
    Grassi, Giuseppina
    Massobrio, Marco
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2006, 4 (1)
  • [24] Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany
    Klaus F. Bühler
    Robert Fischer
    Patrice Verpillat
    Arthur Allignol
    Sandra Guedes
    Emmanuelle Boutmy
    Wilma Bilger
    Emilia Richter
    Thomas D’Hooghe
    Reproductive Biology and Endocrinology, 19
  • [25] Recombinant versus highly-purified, urinary follicle-stimulating hormone (r-FSH vs. HP-uFSH) in ovulation induction: a prospective, randomized study with cost-minimization analysis
    Alberto Revelli
    Francesca Poso
    Gianluca Gennarelli
    Federica Moffa
    Giuseppina Grassi
    Marco Massobrio
    Reproductive Biology and Endocrinology, 4
  • [26] Comparative effectiveness of recombinant human follicle-stimulating hormone alfa (r-hFSH-alfa) versus highly purified urinary human menopausal gonadotropin (hMG HP) in assisted reproductive technology (ART) treatments: a non-interventional study in Germany
    Buehler, Klaus F.
    Fischer, Robert
    Verpillat, Patrice
    Allignol, Arthur
    Guedes, Sandra
    Boutmy, Emmanuelle
    Bilger, Wilma
    Richter, Emilia
    D'Hooghe, Thomas
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2021, 19 (01)
  • [27] Endocrine profile following stimulation with recombinant follicle stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin
    Antonio Requena
    María Cruz
    Francisco J Ruiz
    Juan A García-Velasco
    Reproductive Biology and Endocrinology, 12
  • [28] Efficacy and safety of highly purified hMG vs. recombinant follicle stimulating hormone: A meta-analysis.
    Al-Inany, H. G.
    Abou-Setta, A. M.
    Mansour, R. T.
    Serour, G. I.
    Aboulghar, M. A.
    FERTILITY AND STERILITY, 2007, 88 : S35 - S36
  • [29] Endocrine profile following stimulation with recombinant follicle stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin
    Requena, Antonio
    Cruz, Maria
    Ruiz, Francisco J.
    Garcia-Velasco, Juan A.
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2014, 12
  • [30] COST-EFFECTIVENESS ANALYSIS OF REFERENCE RECOMBINANT HUMAN FOLLICLE-STIMULATING HORMONE ALFA (R-HFSH-ALFA) AND URINARY HIGHLY PURIFIED MENOPAUSAL GONADOTROPIN (HMG-HP) BASED ON DATA FROM A LARGE GERMAN REGISTRY
    Buehler, K.
    Roeder, C.
    Schwarze, J. E.
    Lispi, M.
    Allignol, A.
    D'Hooghe, T.
    Falla, E.
    Lukyanov, V
    Fischer, R.
    VALUE IN HEALTH, 2022, 25 (01) : S108 - S108
12345